Loading...
XSHE
002901
Market cap2.78bUSD
Dec 05, Last price  
48.30CNY
1D
0.00%
1Q
-11.20%
IPO
174.81%
Name

Double Medical Technology Inc

Chart & Performance

D1W1MN
XSHE:002901 chart
P/E
55.04
P/S
9.20
EPS
0.88
Div Yield, %
0.52%
Shrs. gr., 5y
0.73%
Rev. gr., 5y
11.18%
Revenues
2.14b
+39.29%
202,654,587298,891,503391,825,235462,663,858594,014,625772,469,5291,257,317,9981,586,860,2091,994,333,8251,434,099,1801,533,121,2812,135,559,000
Net income
357m
+505.03%
96,812,045139,289,565188,507,182219,328,243295,556,287371,453,093465,490,905605,684,140673,309,41392,555,27658,972,461356,803,000
CFO
442m
+498.82%
106,507,183151,116,863123,443,347207,128,436308,700,299334,876,268433,877,268555,769,602673,261,691128,444,75073,861,966442,300,000
Dividend
Jun 24, 20240.25 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Double Medical Technology Inc. provides services, technologies, and devices in the areas of orthopedics, wound management, neurosurgery, and general surgery in China. It also exports its products to approximately 50 countries and regions, including European Union, Russia, South America, Australia, Southeast Asia, the Middle East, and South Africa. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited. Double Medical Technology Inc. was founded in 2004 and is based in Xiamen, the People's Republic of China.
IPO date
Sep 22, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT